CLOSE
Search

scientists collaborate - search results

If you're not happy with the results, please do another search

by -
0 1716
Anne Churchland with former postdoctoral fellow Matt Kaufman at Cold Spring Harbor Laboratory. The microscope is a 2-photon microscope and is one of three techniques used to measure neural activity in the mouse brain. Photo from Margot Bennett

By Daniel Dunaief

Fidgeting, rocking and other movements may have some benefit for thinking. Yes, all those people who shouted to “sit still” may have been preventing some people from learning in their own way.

In a new experiment conducted on mice published in the journal Nature Neuroscience this week, Anne Churchland, an associate professor at Cold Spring Harbor Laboratory, linked idiosyncratic mouse movements to performance in a set of tasks that required making decisions with rewards.

“Moving when deep in thought is a natural thing to do,” Churchland said. “It deeply engages the brain in ways that were surprising to us.”

She suggested that many people believe thinking deeply requires stillness, like the statue of The Thinker created by Auguste Rodin. “Sometimes it does, but maybe not for all individuals,” adding that these movements, which don’t seem connected to the task at hand, likely provide some benefit for cognition.

“We don’t know yet for sure what purpose these movements are serving,” she said.

Margaret Churchland with the lab group at CSHL

Mammals tend to exhibit a process called “optimal motor control.” If a person is reaching out to grab a cup, she tends to move her arm in a way that is energy conserving. Indeed, extending this to her rodent study, Churchland suggests that somehow these ticks, leg kicks or other movements provide assistance to the brain.

In theory, she suggested that these movements may be a way for the brain to recruit movement-sensitive cells to participate in the process. These brain cells that react to movement may then participate in other thought processes that are unrelated or disconnected from the actions themselves.

Churchland offers an analogy to understanding the potential benefit of these extra movements in the sports world. Baseball players have a wide range of stereotyped movements when they step up to the plate to hit. They will touch their shirt, tug on their sleeves, readjust their batting gloves, lift up their helmet or any of a range of assorted physical activities that may have no specific connection to the task of hitting a baseball.

These actions likely have “nothing to do” with the objective of a baseball hitter, but they are a “fundamental part of what it means to go up to bat,” she said.

In her research, Churchland started with adult mice who were novices at the kinds of tasks she and her colleagues Simon Musall and Matt Kaufman, who are the lead authors on the paper, trained them to do. Over a period of months, the mice went from not understanding the objective of the experiment to becoming experts. The animals learned to grab a handle to start a trial or to make licking movements.

These CSHL researchers tracked the behavior and neural activity of the mice every day.

Churchland said a few other groups have measured neural activity during learning, but that none has studied the kind of learning her lab did, which is how animals learn the structure of an environment.

The extra movements that didn’t appear to have any connection to the learned behaviors transitioned from a disorganized set of motions to an organized pattern that “probably reflected, in the animal’s mind, a fundamental part of what it means to make a decision.”

Churchland suggested that some of these conclusions may have a link to human behavior. Each animal, however, has different behaviors, so “we always need to confirm that what we learn in one species is true for another,” she wrote in an email.

Parents, teachers, coaches and guest lecturers often look at the faces of young students who are shaking their legs, rocking in their chair, twiddling their thumbs or spinning their pens between their fingers. While these actions may be distracting to others, they may also play a role in learning and cognition.

The study “suggests that allowing certain kinds of movements during learning is probably very important,” Churchland said. “When we want people to learn something, we shouldn’t force them to sit still. We should allow them to make movements they need to make which will likely help” in the learning process.

Churchland believes teachers already know that some students need to move. These educators also likely realize the tension between allowing individual students to be physically active without creating a chaotic classroom. “Most teachers are working hard to find the right balance,” she explained in an email.

She also suggested that different students may need their own level of movement to stimulate their thinking.

Some adults may have already developed ways to enhance their own thinking about decisions or problems. Indeed, people often take walks that may “finally allow those circuits you need for a decision to kick in.”

Down the road, she hopes to collaborate with other scientists who are working with nonhuman primates, such as marmosets, which are new world monkeys that live in trees and have quick, jerky movements, and macaques, which are old world monkeys and may be familiar from their island perch in an exhibit in the Central Park Zoo.

Churchland said extensions of this research could also go in numerous directions and address other questions. She is hoping to learn more about attention deficit hyperactivity disorder and the brain.

“We don’t know when that strategy [of using movement to trigger or enhance thinking] interferes with the goal,” she said. “Maybe the movements are a symptom of the learner trying to engage, but not being able to do so.”

Ultimately, Churchland expects that different pathways may support different aspects of decision making, some of which can and likely are connected to movement.

by -
0 2541

By Daniel Dunaief

Screws can’t be the best and only answer. That was the conclusion neurosurgeon Daniel Birk at the Stony Brook Neurosciences Institute came to when he was reconsidering the state-of-the-art treatment for spinal injuries. The screws, which hold the spine in place, create problems for patients in part because they aren’t as flexible as bone.

That’s where Stony Brook University’s College of Engineering and Applied Sciences, headed by Fotis Sotiropoulos, plans to pitch in. Working with Kenneth Kaushansky, dean of Stony Brook University’s Renaissance School of Medicine, the two Stony Brook leaders have been immersed in uniting their two disciplines to find ways engineers can improve medical care.

Fotis Sotiropoulos

The two departments have created the Institute for Engineering-Driven Medicine, which will address a wide range of medical challenges that might have engineering solutions. The institute will focus on developing organs for transplantation, neurobiological challenges and cancer diagnostics.

The institute, which already taps into the medical and engineering expertise of both departments, will move into a new $75 million building at the Research and Development Park, in 2023.

The original investment from New York State’s Economic Development Council was for an advanced computing center. The state, however, had given Buffalo the same funds for a similar facility, which meant that former Stony Brook President Sam Stanley, who recently became the president of Michigan State University, needed to develop another plan.

Sotiropoulos and Kaushansky had already created a white paper that coupled engineering and medicine. They developed a proposal that the state agreed to fund. In return for their investment, the state is looking for the development of economic activity, with spin-off companies, jobs, new industries and new ideas, Kaushansky said.

The two leaders are developing “a number of new faculty recruits to flesh out the programs that are going in the building,” Kaushansky added.

Sotiropoulos, who has conducted research in the past on blood flow dynamics in prosthetic heart valves, believes in the potential of this collaboration. “This convergence of engineering and medicine is already doing what it was intended to do,” he said. Clinicians can get “crazy sci-fi ideas, talk to engineers and figure out a way to make it happen.”

In addition to spinal cord support, researchers in engineering and medicine are working on developing algorithms to make decisions about surgical interventions, such as cesarean sections. 

A recent project from principal investigator Professor Petar Djurić, chair of SBU’s Department of Electrical and Computer Engineering, and Gerald Quirk, an obstetrician and gynecologist at Stony Brook Medicine, recently received $3.2 million from the National Institutes of Health. The goal of the project is to use computer science to assist with the decisions doctors face during childbirth. A potential reduction in C sections could lower medical costs. 

“This is a fantastic example of this type of convergence of engineering and medicine,” said Sotiropoulos.”

Dr. Kenneth Kaushansky. Photo from SBU

While the building will host scientists across a broad spectrum of backgrounds, researchers at Stony Brook will be able to remain in their current labs and coordinate with this initiative. Combining all these skills will allow researchers to apply for more grants and, Stony Brook hopes, secure greater funding.

“For a number of years now, the [National Institutes of Health have] really favored interdisciplinary approaches to important medical problems,” Kaushansky said. “Science is becoming a team sport. The broader range of skills on your team, the more likely you’ll be successful. That’s the underlying premise behind this.”

The notion of combining medicine and engineering, while growing as an initiative at Stony Brook, isn’t unique; more than a dozen institutions in the country have similar such collaborations in place.

“We’re relatively early in the game of taking this much more holistic approach,” said Kaushansky, who saw one of the earlier efforts of this convergence when he was at the University of California at San Diego, where he worked with the Founding Chair of the Department of Bioengineering Shu Chien. 

The Stony Brook institute has created partnerships with other organizations, including Albert Einstein College of Medicine and Montefiore Medical Center.

“The more clinical people we engage, the better it is for the institute,” Sotiropoulos said.

As for the bionic spine, Kaushansky has familial experience with spinal injuries. His mother suffered through several spinal surgeries. “There’s a need for much, much better mechanical weight-bearing device that will help people with back problems,” he said.

At this point, Stony Brook has gone two-thirds of the way through the National Science Foundation process to receive a $10 million grant for this spinal cord research. Sotiropoulos suggested that a bionic spine could be “a game changer.”

While the institute will seek ways to create viable medical devices, diagnostics and even organs, it will also meet the educational mandate of the school, helping to train the next generation of undergraduate and graduate students. The school already has a program called Vertically Integrated Projects, or VIPs, in place, which offers students experiential learning over the course of three or four years. The effort combines undergraduates with graduates and faculty members to work on innovative efforts.

“These projects are interdisciplinary and are all technology focused,” Sotiropoulos said. “We bring together students” from areas like engineering, computer science and medicine, which “go after big questions,” and that the VIP efforts are structured to unite engineers and doctors-in-training through the educational process.

Through the institute, Stony Brook also plans to collaborate with other Long Island research teams at Cold Spring Harbor Laboratory and Brookhaven National Laboratory, Sotiropoulos said, adding that the scientists are “not just interested in doing blue sky research. We are interested in developing services, algorithms, practices, whatever it is, that can improve patient care and costs.”

Indeed, given the translational element to the work, the institute is encouraging a connection with economic development efforts at Stony Brook, which will enable faculty to create spin-off companies and protect their ideas. The institute’s leadership would like to encourage the faculty to “create companies to market and take to market new products and developments,” said Sotiropoulos.

Photos from SBU

by -
0 2019
Mircea Cotlet. Photo courtesy of BNL

By Daniel Dunaief

An innovative scientist in the world of nanostructures, Mircea Cotlet recently scored Inventor of the Year honors from Battelle.

A principal investigator and materials scientist in the Soft and Bio Nanomaterials Group at the Center for Functional Nanomaterials at Brookhaven National Laboratory, Cotlet has conducted a wide range of research over his dozen years on Long Island.

The distinction from Battelle, which manages BNL through Brookhaven Sciences Associates, honors researchers who have made significant scientific or engineering contributions that have societal or financial impacts.

“The award recognizes [Cotlet’s] ongoing contributions to materials science at BNL, specifically his work on low-dimensional semiconductors, 1-D nanowires, and tiny 0-D nanocrystals called quantum dots,” Katy Delaney, a Battelle spokesperson, explained in an email.

Researchers who have worked with Cotlet believe he deserves the honor.

Cotlet is an “extraordinary scientist” who “stands out” for his thorough work and creative approach” said Deep Jariwala, an assistant professor in the Department of Electrical and Systems Engineering at the University of Pennsylvania. Jariwala has known Cotlet for over two years and has collaborated with him over the last year.

Cotlet has “really laid the foundational ground in understanding the rules that govern charge and energy transfer across hybrid quantum confined materials systems that comprise quantum dots, organic molecules–two-dimensional materials as well as biologically photoactive materials,” Jariwala added.

The technologies will impact the science and technologies of sensing, displays and energy harvesting in the future, Jariwala predicted.

Eric Stach, a professor in the Department of Materials Science and Engineering at the University of Pennsylvania who had previously worked at the CFN, said Cotlet “tries to figure out ways of putting together disparate systems at the nanoscale.”

By combining these materials, Cotlet is able to “improve the overall performance” of systems, Stach continued. “He’s trying to tune the ability of a given material system to capture light and do something with it.”

Cotlet recently partnered self-assembled two-dimensional nanoparticles, such as the one-atom-thick graphene, with light-absorbing materials like organic compounds.

The result enhances their ability to detect light, which could be valuable in medical imaging, radiation detection and surveillance applications. The mini-partnership boosted the photoresponse of graphene by up to 600 percent by changing the structure of the polymer.

Indeed, a defense contractor has shown an interest in research they could use for low light level detection applications, Cotlet said.

Like other scientists at BNL, Cotlet not only conducts his own research, but he also helps other scientists who come to the Department of Energy facility to use the equipment at the CFN, to make basic and translational science discoveries.

Cotlet patented a self-assembly process before he published it.

He is continuing conversations with a big company that is exploring the benefits of this type of approach for one of its product, while he is also working with the technology transfer office at BNL to look at the development of photodetectors for low light applications.

“Having graphene and the conductor polymer would absorb light from ultraviolet to visible light,” Cotlet said.

The physics changes from bulk to nanoparticles to nanocrystals, Cotlet said, and he engineers the smaller materials for a given function.

“We basically like to play with the interface between different types of nanomaterials,” he said. “We like to control the light-simulated process.”

Working at an energy department site, he also has experience with solar panels and with light-emitting diodes.

Jariwala described the science as extending to interfaces that also occur in nature, such as in photosynthesis and bioluminescence. “By combining techniques and materials that we have developed and looked at, we hope to answer fundamental mechanistic questions and provide insights into long-standing questions about biological energy conversion processes,” he wrote.

As far as some of the current materials he uses, Cotlet works on graphene and the transition metal dichalcogenides and he explores their potential application as quantum materials. He tries to look for emerging properties coming out of nanomaterials for various applications, but most of his efforts are in basic science.

Jariwala explained that he and Cotlet are seeking to understand the efficient transduction of energy in quantum sized systems when they are brought close to one another in an orderly fashion.

After his upbringing in Romania, where he attended college, Cotlet appreciated the opportunity to learn from one of the pioneering groups in the world in single-molecule microscopy at the Katholieke Universiteit Leuven in Belgium, where he studied for his doctorate.

He also did a fellowship at Harvard, where he worked on unique microscopy, and then went on to conduct postdoctoral work at Los Alamos National Laboratory, where he worked on protein folding and on optimal imaging methods.

Cotlet arrived at the CFN just as the facility was going online.

“The CFN went beyond its original promise for cutting edge science,” he said. The center has been, and he continues to hope it will be, the best place he could dream of to conduct research.

The postdoctoral researchers who have come through his lab have all been successful, either leading their own projects or joining commercial teams.

Up until he was 18, Cotlet wasn’t focused on science, but, rather, anticipated becoming a fighter pilot. He discovered, however, that he had a vision defect.

“All my childhood, I was set up to become a fighter pilot,” but the discovery of a condition called chromatopsy changed his plans.

A resident of Rocky Point, Cotlet lives with his wife, Ana Popovici, who is an administrative assistant at BNL, and their middle school daughter.

As for his future work, he is interested in building on the research into quantum materials.

“I’m looking forward to trying to integrate my research” into this arena, he said.

by -
0 252
Assemblyman Steve Englebright (D-Setauket) during a press conference at Port Jefferson Harbor. The LIPA power plant can be seen in the distance. File photo by David Luces

As the federal government under the current presidential administration has scaled back environmental measures — and at points denied the science behind climate change —members in the New York State Legislature are trying to go about it without the leadership of Uncle Sam.

That is, if it can pass before the end of legislative session.

“New York has to help lead the way, because we’re not getting any leadership at the federal level,” said Assemblyman Steve Englebright (D-Setauket). 

“You can just look at the weather reports for the nation — last year California burned, this year Texas is drowning. The amount of rain we’re getting is a result of an overheated ocean relaying more rain to the atmosphere. And on it goes.”

— Steve Englebright

Englebright, the chair of the environmental conservation committee, is sponsoring the Climate and Community Protection Act, which would establish a New York State Climate Action Council. It would contain 25 members made up of state agencies, scientists and those in the environmental justice, labor and other regulated industries. The council would be able to make recommendations to the state Department of Environmental Conservation to limit greenhouse gases. It would also be asked to report on barriers to and opportunities for community ownership of services and commodities in certain communities, particularly for renewable energy.

“An advisory committee that will have meaningful powers to make recommendations as we go forward — the stakes are so high on this issue,” Englebright said.

In addition, the bill would require the DEC to establish greenhouse gas reporting requirements and limits on emissions.

The bill was passed in the environmental committee and was referred to the ways and means committee in February.

The idea of an advisory committee is not new. A similar advisory panel was suggested in the New York State 2019-20 budget, but it was removed in the final version because some legislators disagreed with the number of people on the board and who would sit on it.

“Instead of 25, [Cuomo] had nine appointees; six of them are his cabinet members,” Englebright said.

In January during the process for crafting the budget, Gov. Andrew Cuomo (D) incited a “Green New Deal,” which would have been “comprised of the heads of relevant state agencies and other workforce, environmental justice and clean energy experts,” according to a January press release. The governor has set goals to reduce greenhouse gas emissions in New York State by 80 percent below the levels emitted in 1990 by the year 2050.

A spokesperson from the governors office said the governor is continuing to collaborate with the legislature on climate policy proposals.

Cuomo appeared on city radio WNYC’s show hosted by Brian Lehrer June 3. When the new climate change legislation was brought up, he said he was looking to attack the issue while not pretending change will happen all at once.

“I believe this is the most pressing issue of our time, but I don’t want to play politics with it and I don’t want to tell people we can move to a carbon free economy in a period of time that I know that we can’t.”

The end of this legislative session is June 19, and Englebright said he is crossing his fingers the bill can pass both assembly and senate before time runs out. 

He said the bill is especially important with the current administration in Washington. The New York Times reported June 3 that 84 environmental rules and regulations are being phased out by Trump and his appointees.

“We are seeing the effects of increased carbon dioxide and methane in the atmosphere on a daily basis,” he said. “You can just look at the weather reports for the nation — last year California burned, this year Texas is drowning. The amount of rain we’re getting is a result of an overheated ocean relaying more rain to the atmosphere. And on it goes.”

by -
0 2228
Gordon Taylor with technician, Tatiana Zaliznyak. A Raman microspectrometer is pictured in the background. Photo by J. Griffin

By Daniel Dunaief

Something is happening in the Twilight Zone of the ocean, but it’s unclear exactly who is involved and how fast the process is occurring. 

Plants and animals are eating, living, defecating and dying above the so-called Twilight Zone and their bodies and waste are falling toward the bottom of the ocean. But most of that matter isn’t making it all the way to the ocean floor.

That’s where Gordon Taylor, a professor and director of the NAno-RAMAN Molecular Imaging Laboratory at the School of Marine & Atmospheric Sciences at Stony Brook University, comes in. 

Taylor and Professor Alexander Bochdansky of Old Dominion University recently received a $434,000 three-year grant to study the way microorganisms eat, process and convert organic carbon — i.e., carbon that’s a part of living organisms like plants, sea birds and whales — into inorganic carbon, which includes carbon dioxide, carbonate, bicarbonate and carbonic acid.

“The inorganic carbon moves back and forth among these four chemical species,” Taylor explained in an email. Understanding the rate at which carbonic acid builds up can and will help lead to a greater awareness of ways the ocean, which used to have a pH around 8.2 — which is slightly basic, as opposed to levels below the neutral 7— is becoming more acidic.

Above, incubators that Alexander Bochdansky has used in Bermuda. The ones Taylor and Bochdansky will analyze will be smaller than these, which won’t require such a large A-frame to deploy. Images courtesy of A. Bochdansky

They will start by deploying the traps at a single depth, about 985 feet, along the ocean off the coast of Virginia. “We are going to look at who the players are,” Bochdansky said. “There might be only a few key players that degrade this organic carbon. With [Taylor’s] great methods, we can measure the uptake rate in single microbes. This is really exciting.”

The Twilight Zone received its name because it is 650 to 3,300 feet below the surface of the water. Some faint light reaches the top of that zone, but most of that region, which includes creatures that use bioluminescence to attract or find prey, is pitch black.

“The directory of which inventories and fluxes decrease [is] still poorly understood,” Taylor said. “Animals eating the material is one mechanism and we don’t know how important that is compared to microbial decomposition or remineralization,” adding that the goal of this project is to “better define the role of microorganisms in returning carbon to the inorganic pool.”

Taylor is exploring this area with new tools that will allow a greater depth of understanding than previously possible. His group has developed new experimental approaches to apply Raman microspectrometry to this problem. The organisms they examine will include bacteria, fungi and protozoans.

Their experiment will explore which organisms are recycling organic carbon, how fast they are doing it and what factors control their activities. Through this approach, Taylor will be able to see these processes down to the level of a single cell as the instrument can identify organisms that have consumed the heavy isotope tracer.

The Raman microspectrometer uses an optical microscope with a laser and a Raman spectrometer. This tool will measure samples that are micrometers thick, which is smaller than the width of a human hair. The microspectrometer can obtain data from a 0.3-micrometer spot in a cell and he has even produced spectra from single viruses.

The scientists will place phytoplankton common to the region in incubators that Bochdansky developed. They will use a heavy carbon isotope, called carbon 13, that is easy to find through these experiments and see how rapidly microorganisms that colonize are incorporating the isotopically labeled carbon.

Taylor and Bochdansky received funding for the project through the Biological Oceanography Program at the National Science Foundation in the Directorate of Geosciences. Twice a year, the division makes open calls for proposals on any topic of interest to researchers. The scientists submit 15 pages of text that the NSF sends to peer reviewers. A panel meets to evaluate the reviews and ratings and decides which projects to fund.

Bochdansky and Taylor have been “acquainted for a long time and have shared similar interests,” Taylor said.

The carbon experiments in the Twilight Zone account for about a quarter of the work Taylor is doing in his lab. The other research also employs Raman microspectrometry. The United States only has one or two other facilities that do environmental research comparable to the one in Taylor’s lab at Stony Brook. Europe also has three such tools, which can look into single cells using lasers.

One of the other projects Taylor hopes to get funded involves studying the distribution of microplastics in the ocean. “The instrument I have is one of the best tools to look at microscopic plastic particles,” because it identifies the plastic polymer and its source, said Taylor, who is awaiting word on funding from the National Oceanic and Atmospheric Administration.

The other work involves exploring viruses that attack plankton.

“We are exploring Raman methods for early detection of viruses that attack plankton,” Taylor explained. Every organism in the ocean has at least one virus that has evolved to attack it.

As for his work on the Twilight Zone, Taylor said the area acts as a filter of sorts because less than 20 percent of the organic material entering at the top exits at the bottom.

Bochdansky added that these microbes are critical to processes that affect oceans and the planet.

“That’s something people often overlook,” Bochdansky said. “We can’t understand the ocean if we don’t understand it at the level or the scale that’s relevant to microbes.”

Bochdansky is thrilled to work with Taylor, who he’s known for years but will collaborate with for the first time on this project.

“In my lab, we have measured the turnover and release of carbon dioxide,” Bochdansky said. In Taylor’s lab, he measures “the actual feeding of microbial cells.”

by -
0 2993
From left, Megan Crow, Associate Professor Jesse Gillis and postdoctoral researcher Sara Ballouz Photo by Gina Motisi/CSHL

By Daniel Dunaief

Diversity has become a buzz word in the workplace, as companies look to bring different perspectives that might represent customers, constituents or business partners. The same holds true for the human brain, which contains a wide assortment of interneurons that have numerous shapes and functions.

Interneurons act like a negative signal or a brake, slowing or stopping the transmission. Like a negative sign in math, though, some interneurons put the brakes on other neurons, performing a double negative role of disinhibiting. These cells of the nervous system, which are in places including the brain, spinal chord and retina, allow for the orderly and coordinated flow of signals.

One of the challenges in the study of these important cells is that scientists can’t agree on the number of types of interneurons.

“In classifying interneurons, everyone argues about them,” said Megan Crow, a postdoctoral researcher in Jesse Gillis’ lab at Cold Spring Harbor Laboratory. “People come to this question with many different techniques, whether they are looking at the shape or the connectivity or the electrophysiological properties.”

Megan Crow. Photo by Constance Brukin

Crow recently received a two-year grant from the National Institutes of Health to try to measure and explain the diversity of interneurons that, down the road, could have implications for neurological diseases or disorders in which an excitatory stimulus lasts too long.

“Understanding interneuron diversity is one of the holy grails of neuroscience,” explained Gillis in an email. “It is central to the broader mission of understanding the neural circuits which underlie all behavior.”

Crow plans to use molecular classifications to understand these subtypes of neurons. Her “specific vision” involves exploiting “expected relationships between genes and across data modalities in a biologically thoughtful way,” said Gillis.

Crow’s earlier research suggests there are 11 subtypes in the mouse brain, but the exact number is a “work in progress,” she said.

Her work studying the interneurons of the neocortex has been “some of the most influential work in our field in the last two to three years,” said Shreejoy Tripathy, an assistant professor in the Department of Psychiatry at the University of Toronto. Tripathy hasn’t collaborated with Crow but has been aware of her work for several years.

The interactivity of a neuron is akin to personalities people demonstrate when they are in a social setting. The goal of a neuronal circuit is to take an input and turn it into an output. Interneurons are at the center of this circuit, and their “personalities” affect the way they influence information flow, Crow suggested.

“If you think of a neuron as a person, there are main personality characteristics,” she explained. Some neurons are the equivalent of extraverted, which suggests that they have a lot of adhesion proteins that will make connections with other cells.

“The way neurons speak to one another is important in determining” their classes or types, she said.

A major advance that enabled this analysis springs from new technology, including single-cell RNA sequencing, which allows scientists to make thousands of measurements from thousands of cells, all at the same time.

“What I specialize in and what gives us a big leg up is that we can compare all of the outputs from all of the labs,” Crow said. She is no longer conducting her own research to produce data and, instead, is putting together the enormous volume of information that comes out of labs around the world.

Megan Crow. Photo by Daniel Katt

Using data from other scientists does introduce an element of variability, but Crow believes she is more of a “lumper than a splitter,” although she would like to try to understand variation where it is statistically possible.

She believes in using data for which she has rigorous quality control, adding, “If we know some research has been validated externally more rigorously than others, we might tend to trust those classifications with more confidence.”

Additionally she plans to collaborate with Josh Huang, the Charles Robertson professor of neuroscience at Cold Spring Harbor Laboratory, who she described as an interneuron expert and suggested she would use his expertise as a “sniff test” on certain experiments.

At this point, Crow is in the process of collecting baseline data. Eventually, she recognizes that some interneurons might change in their role from one group to another, depending on the stimuli.,

Crow hasn’t always pursued a computational approach to research. 

In her graduate work at King’s College London, she produced data and analyzed her own experiments, studying the sensory experience of pain.

One of the challenges scientists are addressing is how pain becomes chronic, like an injury that never heals. The opioid crisis is a problem for numerous reasons, including that people are in chronic pain. Crow was interested in understanding the neurons involved in pain, and to figure out a way to treat it. “The sensory neurons in pain sparked my general interest in how neurons work and what makes them into what they are,” she said.

Crow indicated that two things brought her to the pain field. For starters, she had a fantastic undergraduate mentor at McGill University, Professor of Psychology Jeff Mogil, who “brought the field to life for me by explaining its socio-economic importance, its evolutionary ancient origins, and showed me how mouse behavioral genetic approaches could make inroads into a largely intractable problem.”

Crow also said she had a feeling that there might be room to make an impact on the field by focusing on molecular genetic techniques rather than the more traditional electrophysiological and pharmacological approaches.

As for computational biology, she said she focuses on interpreting data, rather than in other areas of the field, which include building models and simulations or developing algorithms and software.

In the bigger picture, Crow said she’s still very interested in disease and would like to understand the role that interneurons and other cells play. “If we can get the tools to be able to target” some of the cells involved in diseases, “we might find away to treat those conditions.”

The kind of research she is conducting could start to provide an understanding of how cells interact and what can go wrong in their neurodevelopment.

Gillis praises his postdoctoral researcher for the impact of her research.

“Just about any time [Crow] has presented her work — and she has done it a lot — she has ended up convincing members of the audience so strongly that they either want to collaborate, adapt her ideas, or recruit her,” Gillis wrote in an email. 

Crow grew up in Toronto, Canada. She said she loved school, including science and math, but she also enjoyed reading and performing in school plays. She directed a play and was in “The Merchant of Venice.” In high school, she also used to teach skiing.

A resident of Park Slope in Brooklyn, Crow commutes about an hour each way on the train, during which she can do some work and catch up on her reading.

She appreciates the opportunity to work with other researchers at Cold Spring Harbor, which has been “an incredible learning experience.”

by -
0 488
From left, Supervisor Ed Romaine, Councilman Dan Panico, honoree Cathy Cutler and Town of Brookhaven Receiver of Taxes Louis Marcoccia at the March 21 event. Photo from BNL

Cathy Cutler, director of the Medical Isotope Research & Production program at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory, was honored for her scientific accomplishments at Town of Brookhaven’s 33rd annual Women’s Recognition Night, held on March 21 at Town Hall in Farmingville. The Shirley resident was among 13 women honored for their contributions to a variety of fields at a public ceremony that celebrated the significant achievements of local women during Women’s History Month.

At BNL, Cutler and her team collaborate on research with radiopharmaceuticals for cancer therapy, and they make radioisotopes required for this research as well. These radioisotopes would otherwise not be available but are, thanks to the high-energy Brookhaven Linac Isotope Producer (BLIP) that is part of the extensive particle accelerator infrastructure for the Relativistic Heavy Ion Collider — a U.S. Department of Energy Office of Science User Facility for fundamental nuclear physics research located at Brookhaven.

Radiopharmaceuticals are vital for “noninvasive,” personalized cancer treatments that provide patients with high-impact doses to combat tumors without damaging nearby healthy cells. With more than 20 years’ experience developing and evaluating radiopharmaceuticals, Cutler is helping lead their development for “theranostics” that combine medical therapies with diagnostic medical tests.

“I am honored to receive this award from the Town of Brookhaven,” said Cutler, who acknowledged the contributions of her colleagues in the success of her research and the isotope program at BNL. “Brookhaven Lab is one of just a few facilities in the DOE complex that can produce certain critical medical isotopes. We are hopeful that this research will lead to improved treatment options for cancer patients.”

“The Town of Brookhaven is pleased to recognize Cathy Cutler for her achievements as an outstanding scientist, leader, and role model for those aspiring to careers in science, technology, and engineering,” said Town of Brookhaven Supervisor Ed Romaine (R).

Cutler joined BNL in 2015 after earning a doctorate in inorganic chemistry from the University of Cincinnati and spending nearly 17 years at the University of Missouri Research Reactor Center. She serves as a mentor to young scientists, has received numerous awards and holds several patents.

In addition to her role at the lab, Cutler has served as chair of the Society of Nuclear Medicine and Molecular Imaging’s committee on radiopharmaceuticals. She is a board member for the society’s Therapy Center of Excellence and Center for Molecular Imaging Innovation and Translation and an executive board member for the Society of Radiopharmaceutical Sciences.

For more information, please visit www.science.energy.gov.

by -
0 2543
Lori Chan, standing, in the lab with doctoral student Jiabei He. Photo from SBU

By Daniel Dunaief

It’s like a factory that makes bombs. Catching and removing the bombs is helpful, but it doesn’t end the battle because, even after many or almost all of the bombs are rounded up, the factory can continue to produce damaging products.

That’s the way triple-negative breast cancer operates. Chemotherapy can reduce active cancer cells, but it doesn’t stop the cancer stem cell from going back into the cancer-producing business, bringing the dreaded disease back to someone who was in remission.

Scientists who stop these cancer stem cells would be doing the equivalent of shutting down the factory, reducing the possible return of a virulent type of cancer.

Lori Chan, an assistant professor in the Department of Pharmacological Sciences in the Renaissance School of Medicine at Stony Brook University, recently published research in Cell Death & Disease that demonstrated the role of a specific gene in the cancer stem cell pathway. Called USP2, this gene is overexpressed in 30 percent of all triple-negative breast cancers.

Inhibiting this gene reduced the production of the tumor in a mouse model of the disease.

Chan’s results “suggest a very important role [of this gene] in cancer stem cells,” Yusuf Hannun, the director of the Stony Brook University Cancer Center, explained in an email.

Lori Chan with her dog KoKo. Photo by Joshua Lee

Chan used a genetic and a pharmacological approach to inhibit USP2 and found that both ways shrink the cancer stem cell population. She used RNA interference to silence the gene and the protein expression, and she also used a USP2-specific small molecular inhibitor to block the activity of the USP2 protein.

With the knowledge that the cancer stem cell factory population needs this USP2 gene, Chan inhibited the gene while providing doxurubicin, which is a chemotherapy treatment. The combination of treatments suppressed the tumor growth by 50 percent.

She suggested that the USP2 gene can serve as a biomarker for the lymph metastasis of triple-negative breast cancer. She doesn’t know if it could be used as a biomarker in predicting a response to chemotherapy. Patients with a high expression of this gene may not respond as well to standard treatment.

“If a doctor knows that a patient probably wouldn’t respond well to chemotherapy, the doctor may want to reconsider whether you want to put your patient in a cycle for chemotherapy, which always causes side effects,” Chan said.

While this finding is an encouraging sign and may allow doctors to use this gene to determine the best treatment, the potential clinical benefit of this discovery could still be a long way off, as any potential clinical approach would require careful testing to understand the consequences of a new therapy.

“This is the beginning of a long process to get to clinical trials and clinical use,” Hannun wrote. Indeed, researchers would need to understand whether any treatment caused side effects to the heart, liver and other organs, Chan added. 

In the future, doctors at a clinical cancer center might perform a genomic diagnostic, to know exactly what type of cancer an individual has. Reducing the cancer stem cell population can be critically important in leading to a favorable clinical outcome.

A few hundred cancer cells can give rise to millions of cancer cells. “I want to let chemotherapy do its job in killing cancer cells and let [cancer stem cell] targeted agents, such as USP2 inhibitors, prevent the tumor recurrence,” Chan said. 

She urges members of the community to screen for cancer routinely. A patient diagnosed in stage 1 has a five-year survival rate of well over 90 percent, while that rate plummets to 15 to 20 percent for patients diagnosed with stage 4 cancer.

The next step in Chan’s research is to look for ways to refine the inhibitor to make it more of a drug and less of a compound. She is also interested in exploring whether USP2 can be involved in other cancers, such as lung and prostate, and would be happy to collaborate with other scientists who focus on these types of cancers.

For Chan, the moment of recognition of the value of studying this gene in this form of breast cancer came when she compared the currently used drug with and without the inhibitor compound. With the inhibitor, the drug becomes much more effective.

A resident of Stony Brook, Chan lives with her husband, Joshua Lee, who is working in the same lab. The couple, who have a 1½-year-old rescue dog from Korea named KoKo, met when they were in graduate school.

Concerned about snow, which she hadn’t experienced when she was growing up in Taiwan, Chan started her tenure at Stony Brook five years ago on April 1, on the same day a snowstorm blanketed the area. “It was a very challenging first day,” she recalled. She now appreciates snow and enjoys the seasonal variety on Long Island.

Chan decided to pursue a career in cancer research after she volunteered at a children’s cancer hospital in Taiwan. She saw how desperate the parents and the siblings of the patient were. In her role as a volunteer, she played with the patients and with their siblings, some of whom she felt didn’t receive as much attention from parents who were worried about their sick siblings.

“This kind of disease doesn’t just take away one person’s life,” Chan said. “It destroys the whole family.” When she went to graduate school, she wanted to know everything she could about how cancer works.

Some day Chan hopes she can be a part of a process that helps doctors find an array of inhibitors that are effective in treating patients whose cancers involve the overexpression of different genes. “It would be a privilege to participate in this process,” she said.

by -
0 1379
Sean Clouston

By Daniel Dunaief

Every year, the country pauses on 9/11, remembering the victims of the terrorist attacks and reflecting on the safety and security of the country. At the same time, a Stony Brook University study continues not only to remember the first responders but also to understand the physical and mental consequences of the work police, firefighters and other first responders performed in the immediate aftermath of the attacks.

Benjamin Luft

Recently, Sean Clouston, an associate professor in the Department of Family, Population & Preventive Medicine at SBU Renaissance School of Medicine, and Ben Luft, the director of the SBU WTC Health and Wellness Program since 2003, published research in which they demonstrated a link between a protein commonly connected with Alzheimer’s disease to post-traumatic stress disorder, or PTSD, in first responders.

In a small preliminary study, the researchers found a difference in the level of the protein between first responders who are battling chronic PTSD and those who aren’t battling the condition. The Stony Brook scientists published their work in the journal Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring.

The researchers cautioned that the presence of the markers doesn’t necessarily indicate anything about present or future changes in cognitive function.“We don’t know the specificity of the markers,” Luft explained in an email.

Amyloid is generally considered the earliest marker of Alzheimer’s disease, which includes cognitive decline. Some people, however, have significant amounts of amyloid and don’t develop problems with their thinking. Neurodegenerative diseases without amyloid rarely have severe symptoms, which don’t appear to worsen with time.

“This paper doesn’t look at cognitive symptoms,” Clouston said. “We do have papers looking at cognitive impairment and other memory-based differences. It wasn’t a part of this paper.”

The newest research is part of an ongoing program in which the university follows 11,000 responders who came to the World Trade Center. The study for this paper involved a smaller subset of this population. This type of research can and does have application to other studies of people who have traumatic experiences, the scientists suggest.

Most traumatic experiences are unique to each person, as people who suffer physical and emotional trauma in combat often confront the aftereffects of head injuries. Among the first responder population who survived the attacks on 9/11, most of them “faired pretty well physically,” Clouston said. 

“We didn’t have a lot of head injuries. Understanding PTSD in this crowd is really useful for the literature as a whole because it allows us to focus on the long-term psychiatric fallout of an event without worrying about exposures that are different.”

The scientists had at least some idea of the timing and duration of exposures. This research suggests that it might be helpful to think about the kinds of problems that cognitive impairment can cause, which might involve managing other health-related problems.

Luft added that the population they are studying shows the benefit of immediate care. “One thing for sure is that the care of the first responders has to occur very quickly,” he said. “Now that we know the history, the greatest chance you have in mitigating the effect of this type of trauma is to deal with the problem from the get-go.” 

Sean Clouston with his daughter Quinn at Benner’s Farm in Setaukt. with his daughter Quinn. Photo by Rachel Kidman

First responders have benefited from psychotherapy as well as from various pharmacological treatments. Luft suggested that they might even benefit from having therapists available in the field, where they can receive near instantaneous psychological support.

In addition to the psychological trauma, first responders have had physical effects from their work in the aftermath of the attacks, such as respiratory and gastrointestinal problems, as well as autoimmunity issues.

People have these problems because “of the pro-inflammatory effect of PTSD itself,” said Luft. The researchers believe trauma can affect the immune system and the brain.

According to Clouston, the next step with this work is to replicate it with a larger scale. The experiment was “fairly expensive and untried in this population and novel in general, so we started small,” he explained in an email. The scientists would like to “get a larger range of responders and to examine issues surrounding symptomatology and other possible explanations.”

Clouston has been at Stony Brook for six years. Prior to his arrival on Long Island, he worked on a collaborative project that was shared between University College London and the University of Victoria. 

An expert in aging, he felt like his arrival came at just the right time for the WTC study, as many of the first responders were turning 50. After giving talks about the cognitive and physical effects of aging, he met Luft and the two decided to collaborate within six months of his arrival.

Clouston is focused on whether PTSD caused by the terrorist attacks themselves have caused early brain aging. A self-proclaimed genetics neophyte, he appreciates the opportunity to work with other researchers who have considerably more experience in searching for molecular signatures of trauma.

Clouston said his family has suffered through the trauma of cognitive decline during the aging process. His family’s struggles “definitely bring [the research] home,” reminding him of the “terror that many family members feel when they start noticing problems in their siblings, parents, spouses, etc.”

As for his work on the recent study, he said he is excited about the next steps. “Little is known about the subtypes of amyloid,” he suggested and there’s a “lot more to explore about the role [of this specific type] in the population. I do think it could be really informative about the types of symptoms.”

by -
0 2822
Alexander Orlov, right, with former students, Peichuan Shen and Shen Zhao. File photo

By Daniel Dunaief

Alexander Orlov knows first-hand about the benefits and dangers of technology. A native of the Ukraine, Orlov and his family lived close enough to Chernobyl that the 1986 nuclear power plant disaster forced the family to bring a Geiger counter to the supermarket. In his career, the associate professor in the Material Science and Chemical Engineering Department at Stony Brook University has dedicated himself to unlocking energy from alternatives to fossil fuels, while he also seeks to understand the environmental consequences of the release of nanoparticles.

Orlov, who is a member of a US-EU working group on Risk Assessment of Nanomaterials and has served as science adviser to several congressmen, the EU Commission and governments in Europe and Asia, recently spoke with Times Beacon Record News Media about this expanding scientific field.

Alexander Orlov File photo

TBR: Is a big part of what you do understanding the way small particles can help or hurt people and the environment?

Orlov: Yes, we have two lines of research. The first is to make efficient nanoparticles, which can help create sustainable energy by creating energy from water or by taking carbon dioxide, which is greenhouse gas, and converting it into fuel. On the other side, we have a project, which is looking at the dangers of nanoparticles in the environment, because there are more and more products, thousands, which contain nanoparticles. We are trying to understand the mechanism of release of those particles.

TBR: How do you monitor the release of nanomaterials?

Orlov: We use labels, and we track them. If they are released from consumer products, it’s not necessarily that they are immediately dangerous. They can be. We are trying to quantify how much is released.

TBR: How do you determine toxicity?

Orlov: In the scientific arena, there is a qualitative discussion, if chemicals or nanomaterials are released, they will be toxic. That is only the beginning. We need to discuss how much is released. There’s a principal in toxicology that everything is toxic. If you drink too much water, it can be toxic and you can die. Similar [rules] apply for nanomaterials. If there is a little released, the danger might be minimal. If it’s too much, that’s where you might get concerned. [The amount of a nanomaterial released] is often not quantified. That’s what we are trying to do.

TBR: How do you determine what might be toxic over a prolonged period of time?

Orlov: What we have in our studies are determined by funding. Normally, funding for scientific research has a three-year window. The studies have been done over the course of years, but not decades, and so the cumulative exposure is still an open question. Another problem is that different scientific groups study nanomaterials which are not the same. That means there are so many variants. Sometimes, navigating the literature is almost impossible.

TBR: Are the studies on toxicity keeping up with the development of new products?

Orlov: [The technology is] developing so fast. New materials are coming from different labs and have so many potential applications, which are exciting and novel in their properties. People studying safety and toxicity often can’t catch up with what they are studying in their lab.

TBR: Are there efforts to recapture nanomaterials released into the environment?

Orlov: Once released, it’s difficult to recapture. [It’s almost] like air pollution, where as soon as it’s in the atmosphere, it can go anywhere. There are industries that use nanomaterials. Soon, you’ll see 3-D printers in the household; 3-D printers would use polymers and embedded nanomaterials. There are already products like this. The question is how you would minimize consumer exposure. There are several ways: design safer products where nanomaterials aren’t going to be released; apply the standard methods of occupational safety; put equipment in ventilated environment; and you can also try to calculate the exposure.

TBR: Are you monitoring nanomaterials in some of these applications?

Orlov: The research we’ve done demonstrated that, even though you have something in polymer or in consumer products, [there is] still [the] possibility of release of nanomaterials, even though it is considered safe. The polymer itself can degrade.

TBR: Do you have any nanoparticle nightmares?

Orlov: Often, the only nightmares I have is that my understanding of the field is so minuscule given that the field is expanding so fast. The amount of knowledge generated and papers published in this is so vast that no single individual can have a comprehensive knowledge in this field. The only way to address it is to collaborate.

TBR: How is the funding environment?

Orlov: In the United States, there’s a significant amount of funding in both fundamental and applied research, but the policy priorities change in certain areas such as environmental protection, so that affects scientists who are working in the environmental area. I teach environmental classes at Stony Brook. Students ask whether it makes sense to go into environmental protection because of the current funding and general policies.

TBR: What do you advise them to do?

Orlov: I tell them priorities change. At the end of the day, would they like to have clean water and a healthy environment and healthy humans? You can find a niche. It doesn’t make sense to abandon this area.

TBR: You experienced the fallout from Chernobyl firsthand. How often do you think about this?

Orlov: I do think about this often for several reasons. There is an overlap in energy and the environment. This idea that scientific discoveries have positive and negative impacts on humanity came during that time. When I was in the Ukraine and disaster happened, I think about this a lot of times.

TBR: How does a career in science compare to your expectations?

Orlov: My original thinking is that after you get to a certain level, you have a more measured life, in terms of free time and time spent in research. I didn’t realize that the amount of funding or probability of getting funding is becoming very low. When I looked at my colleagues who were scientists 30 years ago, they had a five times higher chance of getting funding compared to right now. Being in science is not as relaxing and it can be stressful and the thing is, if you only focus on getting funding, the creativity can suffer.

TBR: Are there other examples of the dichotomy between scientific promise and destruction?

Orlov: In my introductory lecture to chemical engineers at Stony Brook, one scientist who affected more people than Stalin or Hitler was a German scientist who developed the process of converting nitrogen [gas] to ammonia [which is used for fertilizer]. Half of the population exists because of this scientific discovery. [One of the inventors, Fritz Haber, received the Nobel Prize in Chemistry in 1918 for this work, called the Haber-Bosch process].

TBR: What else did he do?

Orlov: Haber had a dark side to him. He was involved in developing chemical weapons for Germans [which were used during World War I and World War II]. The [extension of his] discoveries killed millions of people [including Haber’s relatives in World War II after he died]. Considered the father of chemical warfare, he developed the process of weaponizing chlorine gas. This is [a way] to discuss the ethics of scientific discovery.

TBR: How would people learn about these examples?

Orlov: Stony Brook and other universities are trying to teach ethics to engineers and scientists because this is a perfect example of the dark side of science and how science and policy overlap.

Prev1...567...11Next Page 6 of 11
TBR News Media is your local news and entertainment website.
We provide you with the latest breaking news and information for your community.
Contact us: [email protected]

Most Viewed

©